Suppr超能文献

一名小儿患者可乐定撤药时出现高血压危象。

Hypertensive Crisis in a Pediatric Patient Experiencing Clonidine Withdrawal.

作者信息

Cao Can, Lorenz Matthew L, Sojka Phillip, Brindle Allison W, Topor Lisa Swartz

机构信息

The Warren Alpert Medical School of Brown University, Providence, RI, USA.

Department of Internal Medicine, Rhode Island Hospital, Providence, RI, USA.

出版信息

Case Rep Pediatr. 2022 Mar 22;2022:9005063. doi: 10.1155/2022/9005063. eCollection 2022.

Abstract

BACKGROUND

Clonidine, a central alpha-adrenoreceptor agonist, was initially developed as an antihypertensive. Though no longer commonly used for its original indication due to rebound hypertension after discontinuation, it is currently widely prescribed as a treatment for many pediatric indications including sleep disorders, behavioral concerns, and attention deficit hyperactivity disorder. . We describe a girl who developed prolonged symptoms of clonidine withdrawal, including hypertension and elevated serum metanephrines. . Clonidine withdrawal in pediatric patient can present with hypertensive urgency and other signs of sympathetic stimulation. Withdrawal can also lead to dramatic elevation in serum metanephrines. Treatment with a clonidine taper will reduce development of withdrawal symptoms.

CONCLUSION

Given the rise in clonidine use in pediatric patients, clinicians should be aware of the risk of clonidine withdrawal and how to recognize and avoid its development.

摘要

背景

可乐定是一种中枢性α-肾上腺素能受体激动剂,最初被开发用作抗高血压药。尽管由于停药后出现反弹性高血压,它不再常用于其最初的适应证,但目前它被广泛用于治疗许多儿科疾病,包括睡眠障碍、行为问题和注意力缺陷多动障碍。我们描述了一名出现可乐定戒断症状延长的女孩,包括高血压和血清间甲肾上腺素升高。儿科患者可乐定戒断可表现为高血压急症和其他交感神经刺激症状。戒断还可导致血清间甲肾上腺素显著升高。逐渐减少可乐定用量进行治疗可减少戒断症状的发生。

结论

鉴于儿科患者中可乐定使用的增加,临床医生应意识到可乐定戒断的风险以及如何识别和避免其发生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72eb/8964232/c41702dceaf9/CRIPE2022-9005063.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验